Chair Sven Bulterijs
17:15 - 17:30 Brian Kennedy Biomarkers and interventions (TBC)
17:30 - 17:45 Conboy Irina Resetting Aged Blood to Restore Youth
17:45 - 18:00 Greg Fahy Restoring immune function and causing epigenetic biomarkers to show rejuvenation.
18:15 - 18:30 Josh Mitteldorf AMBAR trial and biomarkers
18:30 - 18:45 Ilia Stambler Developing diagnostic evaluation criteria for aging and aging-related multimorbidity – The basis for developing and testing anti-aging diagnostics and therapies
18:45 - 19:00 Nir Barzilai Longevity genes (TBC)
19:00 - 19:15 Pause
Biomarkers of aging
Chair Ilia Stambler.
19:15 - 19:30 Aubrey De Grey The Importance of Physical Biomarkers for Aging
19:30 - 19:45 Anton KulagaFederated learning and Patient data and biomarkers
19:45 - 20:00 Alex Zhavoronkov Deep biomarkers of aging and longevity
20:00 - 20:15 Polina Mamoshina Deep biomarkers of aging and longevity
20:15 - 20:30 Sven Bulterijs (Heales vzw, Belgium) Biomarkers of aging
20:30 - 20:45 Aleksey MoskalevBiomarkers of human aging
20:45 - 21:00 Joao Pedro Magalhaes
Legal, scientific, technical, and political aspects. concerning Clinical tests and biomarkers
Chair Alexander Tietz
21:00 - 21:15 Didier Coeurnelle How to favor clinical tests on longevity.
21:15 - 21:30 David Wood "Enabling a surge of public interest in biomarkers of aging".
21:30 - 21:45 General discussion Isabelle Schiffer, George Perry and José Cordeiro
The Longevity Investors Conference provides relevant insights into the subject, expert education, investment opportunities, excellent networking opportunities and a great setting in an exclusive location.